I actually think it's higher, but as everything happens at the margin and we are cashflow negative, nothing will change until we turn that around.
I have learned through owning medtech and biotech shares is that doctors are very conservative and will only change their protocols when forced or when the weight of evidence is overwhelming. It means that this share will take a long time to reach its ultimate potential/fair value.
So with little cash left and negative cashflow, there's more dilution coming.
There is also no interest from insiders!
Bell Potter fined in 2017 for price manipulation, page-3
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.29M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 26.5¢ | 26.5¢ | $5.656K | 21.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12409 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
26.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 26.5¢ | 26.5¢ | 26.5¢ | 1688 | ||
| Last updated 15.56pm 07/06/2024 ? | |||||
| NXS (ASX) Chart |